In previous studies, high IDO1 expression in CRC was significantly correlated with a reduction in CD3-positive TILs and the presence of metastatic disease, revealing the important role of IDO1 in the therapeutic blockade for this disease. Here, IDO1 is linked to metastatic neoplasm.